🇺🇸 FDA
Patent

US 7258859

Method for the treatment of multiple sclerosis

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 7258859 (Method for the treatment of multiple sclerosis) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K31/7052